bf/NASDAQ:ALDX_icon.jpeg

COM:ALDEYRA

Aldeyra Therapeutics, Inc.

  • Stock

USD

Last Close

4.81

22/11 21:00

Market Cap

202.01M

Beta: -

Volume Today

652.02K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
262.78K
-
gross profit
-262.78K
-
selling and marketing expenses
-262.78K
-
general and administrative expenses
2.13M
-
3.56M
66.91%
4.41M
23.90%
5.52M
25.04%
6.19M
12.06%
9.88M
59.66%
12.15M
23.07%
9.99M
17.85%
11.28M
12.99%
15.37M
36.26%
13.34M
13.26%
selling general and administrative expenses
2.13M
-
3.56M
66.91%
4.41M
23.90%
5.52M
25.04%
6.19M
12.06%
9.88M
59.66%
12.15M
23.07%
9.99M
17.85%
11.28M
12.99%
15.37M
36.26%
13.07M
14.97%
research and development expenses
1.54M
-
3.71M
140.49%
7.57M
104.30%
13.18M
73.95%
16.30M
23.73%
29.82M
82.93%
44.35M
48.72%
24.68M
44.35%
44.94M
82.07%
47.31M
5.27%
29.46M
37.73%
other expenses
720.78K
-
2.33M
222.91%
cost and expenses
3.68M
-
7.27M
97.76%
11.99M
64.90%
18.70M
55.94%
22.49M
20.28%
39.70M
76.53%
56.51M
42.34%
34.67M
38.65%
56.22M
62.17%
62.68M
11.49%
42.79M
31.73%
operating expenses
3.68M
-
7.27M
97.76%
11.99M
64.90%
18.70M
55.94%
22.49M
20.28%
39.70M
76.53%
56.51M
42.34%
34.67M
38.65%
56.22M
62.17%
62.68M
11.49%
42.53M
32.15%
interest expense
159.32K
-
244.17K
53.26%
112.31K
54.01%
105.51K
6.05%
113.45K
7.53%
146.79K
29.38%
603.85K
311.36%
1.90M
215.34%
1.74M
8.51%
1.69M
2.76%
2.07M
22.27%
ebitda
-3.68M
-
-7.27M
97.77%
-11.98M
64.75%
-18.59M
55.23%
-22.23M
19.54%
-38.75M
74.32%
-54.97M
41.86%
-34.32M
37.56%
-56.03M
63.28%
-60.33M
7.67%
-42.53M
29.50%
operating income
-3.68M
-
-7.27M
97.76%
-11.99M
64.90%
-18.70M
55.94%
-22.49M
20.28%
-39.70M
76.53%
-63.07M
58.88%
-36.42M
42.26%
-56.22M
54.36%
-62.68M
11.49%
-42.79M
31.73%
depreciation and amortization
31
-
1.07K
3,348.39%
18.78K
1,656.59%
35.79K
90.61%
37.85K
5.75%
71.00K
87.60%
8.11M
11,320.79%
2.10M
74.07%
185.36K
91.18%
2.35M
1,167.49%
262.78K
88.82%
total other income expenses net
16.90M
-
2.33M
86.22%
-101.18K
104.35%
-3.47K
96.57%
147.80K
4,356.88%
805.91K
445.27%
937.50K
16.33%
-1.61M
271.94%
-1.56M
3.43%
655.35K
142.10%
5.25M
701.34%
income before tax
13.06M
-
-5.19M
139.72%
-12.09M
133.08%
-18.70M
54.67%
-22.34M
19.47%
-38.89M
74.09%
-62.14M
59.76%
-38.03M
38.79%
-57.78M
51.91%
-62.02M
7.35%
-37.54M
39.47%
income tax expense
159.29K
-
243.10K
52.62%
-7.65K
103.15%
66.25K
965.72%
223.40K
237.24%
952.70K
326.45%
-1.31M
237.50%
-479.26K
63.41%
1.48M
408.37%
-655.35K
144.34%
net income
13.06M
-
-5.19M
139.72%
-12.09M
133.08%
-18.70M
54.67%
-22.34M
19.47%
-38.89M
74.09%
-60.83M
56.39%
-37.55M
38.26%
-59.25M
57.79%
-61.37M
3.57%
-37.54M
38.83%
weighted average shs out
327.37K
-
3.82M
1,066.33%
8.63M
126.13%
11.35M
31.48%
15.92M
40.25%
21.69M
36.20%
27.11M
25.02%
33.97M
25.28%
54.04M
59.11%
58.41M
8.07%
58.94M
0.92%
weighted average shs out dil
4.80M
-
3.85M
19.81%
8.63M
124.22%
11.35M
31.48%
15.92M
40.25%
21.69M
36.20%
27.11M
25.02%
33.97M
25.28%
54.04M
59.11%
58.41M
8.07%
58.94M
0.92%
eps
3.39
-
-1.36
140.12%
-1.40
2.94%
-1.65
17.86%
-1.40
15.15%
-1.79
27.86%
-2.24
25.14%
-1.11
50.45%
-1.10
0.90%
-1.05
4.55%
-0.64
39.05%
epsdiluted
-3.14
-
-1.35
57.01%
-1.40
3.70%
-1.65
17.86%
-1.40
15.15%
-1.79
27.86%
-2.24
25.14%
-1.11
50.45%
-1.10
0.90%
-1.05
4.55%
-0.64
39.05%

All numbers in USD (except ratios and percentages)